Pigment Cell & Melanoma Research

Papers
(The median citation count of Pigment Cell & Melanoma Research is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Issue Information46
34
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy29
29
Cytoglobin functions as a redox regulator of melanogenesis in normal epidermal melanocytes28
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)27
Oral Melanoma in Older Adults: Epidemiology, Molecular Landscape, and Treatment Strategies26
SASH1 Mutations and Hereditary Disorders of Pigmentation: Review of Literature20
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma20
Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing19
Let’s talk about sex: A biological variable in immune response against melanoma19
Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS‐derived melanocytes18
Issue Information17
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 614
Microfluidic Characterization and Analysis of Circulating Tumor Cells From Patients With Metastatic Melanoma14
25th International Pigment Cell Conference, Bilbao, Spain IPCC 202314
Issue Information14
Progress in melanoma treatment: Patient's perspectives14
Issue Information13
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma13
The Melanocyte and Nerve Fiber Cross‐Talk, Facilitated Also by Semaphorin‐4A, Enhances UV‐B‐Induced Melanogenesis12
11
Abstracts11
Issue Information11
Corrigendum10
PASPCR 2024 Annual Meeting, New York, NY9
Neratinib kills B‐RAF V600E melanoma via ROS‐dependent autophagosome formation and death receptor signaling9
Corrigendum9
Issue Information9
Sex Differences in Acral Lentiginous Melanoma: A Retrospective Cohort Analysis of 3617 Cases From the Surveillance, Epidemiology, and End Results Database8
Celebrating the life of James J. Nordlund, MD, a larger‐than‐life scholar, mentor, and friend8
Cover Image7
Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population7
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma7
7
Mouse Tail‐Skin Dissociation and Preparation of Live Single‐Cell Suspension for Downstream Analysis of Melanocytes7
BORIS/CTCFL‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melanoma cells7
Single‐cell profiling of MC1R‐inhibited melanocytes7
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models7
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 20236
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐16
The delicate relation between melanocytes and skin immunity: A game of hide and seek6
6
Cover Image6
Dominant Negative Mitf Allele Impacts Melanophore and Xanthophore Development and Reveals Collaborative Interactions With Tfec in Zebrafish Chromatophore Lineages6
Issue Information6
6
Issue Information6
Cover Image5
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment5
The metabolism of melanin synthesis—From melanocytes to melanoma5
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance5
2‐Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity5
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation5
Topical antibiotics limit depigmentation in a mouse model of vitiligo5
The OSUMMER lines: A series of ultraviolet‐accelerated NRAS‐mutant mouse melanoma cell lines syngeneic to C57BL/65
Three‐dimensional imaging for the analysis of human epidermal melanocytes5
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo5
The Proposed Categorization of Vitiligo Lesions on the Hands5
UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production5
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model5
Issue Information4
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab4
Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients with Uveal Melanoma4
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants4
ToFSIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma4
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era4
Patient Education in the Eye of the Beholder: Assessing the Effect of Skin Color Representation in Melanoma Educational Materials4
Prognostic and Predictive Value of ctDNA for Metastatic Uveal Melanoma: A Systematic Review and Meta‐Analysis4
Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment4
Pigmentation and Retinal Pigment Epithelium Thickness: A Study of the Phenotypic and Genotypic Relationships Between Ocular and Extraocular Pigmented Tissues4
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism4
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines4
3
3
Segregation Between an Ornamental and a Disease Driver Gene Provides Insights Into Pigment Cell Regulation3
Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy3
Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas3
Xenopus as a model system for studying pigmentation and pigmentary disorders3
Optimisation of skin phototype classification3
Interplay of Light, Melatonin, and Circadian Genes in Skin Pigmentation Regulation3
Issue Information3
TFE3 promotes ferroptosis in melanoma3
Primary cutaneous melanoma in Black patients: An analysis of 2464 cases from the National Cancer Database 2004–20183
Myron Gordon Award Lecture 2023: Painting the neural crest: How studying pigment cells illuminates neural crest cell biology3
Advancements in melanoma cancer metastasis models3
New Dermoscopy Pattern in Nevus‐Associated Melanomas3
Issue Information3
Association of Pretreatment Tumour Microenvironment and Treatment Outcome in Patients With Locally Advanced Melanoma Treated With Isolated Limb Perfusion3
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis3
Corrigendum3
3
Cutaneous Pigment Cell Distributions and Skin Structure of Xenopus3
Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation3
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State3
3
In Memoriam: Soldano Ferrone MD, PhD (1940–2023)2
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage2
Trained immunity in the pathogenesis of vitiligo2
Establishment and characterization of an immortalized human giant congenital melanocytic nevi cell line2
A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment2
Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)2
Piceatannol—Can It Be Used to Treat Hyperpigmentation of the Skin?2
Identification and functional assays of single‐nucleotide variants of opsins genes in melanocytic tumors2
Low‐Dose Baricitinib Plus Narrow‐Band Ultraviolet B for the Treatment of Progressive Non‐Segmental Vitiligo: A Prospective, Controlled, Open‐Label Study2
The Role of Two Tyrosinase‐Like Glycoenzymes in Defining the Final Hue of Parrot Plumage2
Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations2
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study2
An in vitro nevus explant model for studying the effects of ultraviolet radiation2
YAP Upregulation Contributes to Acquired Resistance to BET Inhibitors in Uveal Melanoma2
RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response2
Protein‐based classification of melanoma differentiation subtypes2
X and Y Differences in Melanoma Survival Between the Sexes2
Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma2
Cover Image2
The classification of melanocytic gene signatures2
Conjunctival Melanoma: A Narrative Review of Current Knowledge2
The Neuro‐Endocrinal Regulation in Vitiligo2
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care2
The Yucatan miniature swine as a model for post‐inflammatory hyperpigmentation1
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities1
Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series1
YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)1
Genotypic spectrum of albinism in Mali1
List of reviewers for PCMR (01.01.2023–30.09.2023)1
The 21st International Congress of the Society for Melanoma Research1
Melanoma and Matrimony: Retrospective Study of Demographics, Marital Status, and Clinical Features of Patients With Acral Melanoma at a Single Academic Center1
AP‐3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio)1
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants1
Cover Image1
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort1
1
The Incorporation of Melanosomes by Senescent Keratinocytes Causes the Accumulation of Melanin due to Decreased Energy Metabolism1
Issue Information1
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis1
B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas1
1
List of Reviewers for PCMR1
Oncogenic properties via MAPK signaling of the SOX5‐RAF1 fusion gene identified in a wild‐typeNRAS/BRAF giant congenital nevus1
Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus‐like features1
Cholinergic Signaling Mediated by Muscarinic Receptors Triggers the Ultraviolet‐Induced Release of Melanosome in Cultured Melanoma Cells1
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL0
Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease Propagation0
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer0
0
Development and Validation of Vitiligo‐Specific‐Belief About Therapy Questionnaire (BTQ‐Vitiligo)0
0
Bay 11‐7082, an NFκB Inhibitor, Prevents Post‐Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis0
Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first‐line anti‐programmed death‐1 monotherapy: A real‐world multicentre observational0
MitoCur‐1 induces ferroptosis to reverse vemurafenib resistance in melanoma through inhibition of USP140
Many Faces of Melanoma: A Comparison Between Cutaneous, Mucosal, Acral, Nail, and Ocular Malignancy0
MITF deficiency and oncogenic GNAQ each promote proliferation programs in zebrafish melanocyte lineage cells0
The effect of oxidative degradation of Dopa‐melanin on its basic physicochemical properties and photoreactivity0
Brief history of the Society for Melanoma Research: A community of clinicians, researchers, and friends0
Survival benefit of sentinel lymph node biopsy in Asian melanoma patients0
A Unique Signature for Cancer‐Associated Fibroblasts in Melanoma Metastases0
Nrf2 protein in melanoma progression, as a new means of treatment0
Journey through the spectacular landscape of melanocortin 1 receptor0
The MFSD12 p.Tyr182His common variant is sufficient to alter mouse agouti coat color0
Synonymous but Significant: New Findings of Pathological Variants in Hermansky–Pudlak Syndrome0
A Ball Python Colour Morph Implicates MC1R in Melanophore–Xanthophore Distribution and Pattern Formation0
Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma0
MITF E318K: A rare homozygous case with multiple primary melanoma0
Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment0
0
25th Annual meeting of the European Society for Pigment Cell Research, Marseille, France0
Diversity, equity, and inclusion in the melanoma research community0
The MITF regulatory network in melanoma0
20th Anniversary of the Society for Melanoma Research: Celebrating two decades of progress in melanoma research0
Issue Information0
Issue Information0
Neurological Mechanisms Exploration and Therapeutic Targets in Segmental Vitiligo Accompanied by White Hair0
Consideration of possible effects of vitamin D on established cancer, with reference to malignant melanoma0
Genetically engineered multicistronic allele of Pmel yielding highly specific CreERT2‐mediated recombination in the melanocyte lineage0
Database for queries of melanoma cohorts with molecular and clinical data0
The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma0
Seasonal variation in effect of anti‐PD‐1 initiation on overall survival among patients with advanced melanoma0
An In Vivo Study of LNS8801, a GPER Agonist, in a Spontaneous Melanoma‐Prone Mouse Model, TGS0
Varicella‐zoster virus in actively spreading segmental vitiligo skin: Pathological, immunochemical, and ultrastructural findings (a first and preliminary study)0
Epilogue0
Issue Information0
Disruption of mc1r Disturbs Skin Pigmentation in Xenopus tropicalis0
Impact of Drug–Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real‐World Study0
Systematic review and meta‐analysis of genomic alterations in acral melanoma0
Vitiligo non‐responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentation0
Eosinophils and melanoma: Implications for immunotherapy0
Beta‐Blockers and Cutaneous Melanoma Outcomes: A Systematic Review and Random‐Effects Meta‐Analysis0
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti‐CTLA‐4 treatment0
Curation of OCA2 Variants of Uncertain Significance From Chinese Oculocutaneous Albinism Patients Based on Multiplex Assays0
Quality Analysis of Measurement Properties of Patient‐Reported Outcome Measures for Vitiligo and of the Studies Assessing Them: A Systematic Review0
Cell‐intrinsic melanin fails to protect melanocytes from ultraviolet‐mutagenesis in the absence of epidermal melanin0
Issue Information0
Issue Information0
PRMT6 Inhibits Malignant Progression of Melanoma by Antagonizing Trimethylation of Histone H3K4 to Downregulate ALDH1A1 Levels0
Interferon‐gamma induces melanogenesis via post‐translational regulation of tyrosinase0
High‐Risk Melanoma: Stage Before Operating0
Unusual Autosomal Dominant Inheritance of Oculocutaneous Albinism Type 4 (OCA‐4): Clinical and Functional Features From A Chinese Family0
Conventional suspension delivery versus tattooing pen‐assisted suspension delivery in non‐cultured epidermal cell suspension procedure for vitiligo: A randomized controlled trial0
Prognostic biomarkers for survival in mucosal melanoma0
0
Image analysis systems to calculate the surface area of vitiligo lesions: A systematic review of measurement properties0
0
Small extracellular vesicle‐based human melanocyte and melanoma signature0
IPCC2023: Looking for translational opportunities by persevering in basic pigment cell research0
Reconstructed human pigmented skin/epidermis models achieve epidermal pigmentation through melanocore transfer0
Generation of Pmel‐dependent conditional and inducible Cre‐driver mouse line for melanocytic‐targeted gene manipulation0
Joining PCMR: Aspirations for Editorial Contributions0
In memoriam Beatrice Mintz (1921–2022)0
Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children0
Photobiomodulation Using 830 nm Lighting‐Emitting Diode Inhibits Melanogenesis via FOXO3a in Human Melanocyte0
Revisiting the role of varicella zoster virus in segmental vitiligo0
Overview of current melanoma therapies0
Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage0
Multi‐omics analysis reveals inflammatory biomarkers for skin melanoma prognosis0
Epidermotropic Metastatic Melanoma Presenting as Eruptive Primary Melanomas0
New insights into the pathogenesis of Hermansky–Pudlak syndrome0
Cover Image0
Anti‐melanogenic effect of exosomes derived from human dermal fibroblasts (BJ‐5ta‐Ex) in C57BL/6 mice and B16F10 melanoma cells0
Genetic insights into Tietz albinism‐deafness syndrome: A new dominant‐negative mutation in MITF0
Uric acid is a major chemical constituent for the whitish coloration in the medaka leucophores0
PURPL Represses Radiation‐Induced Apoptosis to Promote Radioresistance in Cutaneous Melanoma by Direct Interfering With BID Cleavage0
Age and urban–rural disparities in cutaneous melanoma mortality rates in the United States during the COVID‐19 pandemic0
Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma0
NR2F1 regulates a Schwann cell precursor‐vs‐melanocyte cell fate switch in a mouse model of Waardenburg syndrome type IV0
Issue Information0
Dynamic regulation of chromatin accessibility during melanocyte stem cell activation0
Issue Information0
Prediagnostic serum 25‐hydroxyvitamin D and leptin in relation to melanoma‐specific death and overall death0
Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross‐sectional study in 684 melanoma patients0
Issue Information0
Molecular skin fluorescence imaging: A tool for evaluating early melanoma development0
0
Alteration of Hair Melanin in Patients With Mowat–Wilson Syndrome: The Role of the ZEB2 Gene in Regulating Melanogenesis Through SLC45A20
Identification and characterization of the compound heterozygous variants of TYR gene in a northern Chinese family with Oculocutaneous albinism type 10
0
Laser capture microdissection provides a novel molecular profile of human primary cutaneous melanoma0
A meta‐analysis of the placebo response in vitiligo: Causes and consequences for the interpretation of clinical trials0
Undereducation is afoot: Assessing the lack of acral lentiginous melanoma educational materials for skin of color0
Cancer‐Associated Fibroblast Signature Can Predict Prognosis and Therapeutic Responses in Skin Cutaneous Melanoma0
Meeting Abstracts of the ESPCR 2025 (European Society for Pigment Cell Research)0
Issue Information0
Next‐generation of melanoma researchers: Trainee perspectives from around the world0
Issue Information0
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity0
Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study0
Artificial intelligence and melanoma: A comprehensive review of clinical, dermoscopic, and histologic applications0
Twenty years of research in melanoma therapy–From “nothing works” to cures: A personal account0
Clinical Prognostic Factors Predicting Outcomes in Vitiligo: A Scoping Review0
0
List of reviewers for PCMR (01.01.2021–30.09.2021)0
0.47895693778992